Synergy Asset Management LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 106.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,075 shares of the healthcare conglomerate's stock after purchasing an additional 8,305 shares during the period. Synergy Asset Management LLC's holdings in UnitedHealth Group were worth $8,733,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the company. Strategic Planning Group LLC increased its position in shares of UnitedHealth Group by 3.1% in the fourth quarter. Strategic Planning Group LLC now owns 10,215 shares of the healthcare conglomerate's stock valued at $5,168,000 after acquiring an additional 304 shares during the last quarter. Gries Financial LLC increased its position in UnitedHealth Group by 10.6% during the fourth quarter. Gries Financial LLC now owns 1,791 shares of the healthcare conglomerate's stock worth $906,000 after buying an additional 172 shares during the last quarter. Hanson & Doremus Investment Management boosted its position in UnitedHealth Group by 112.9% during the fourth quarter. Hanson & Doremus Investment Management now owns 892 shares of the healthcare conglomerate's stock worth $451,000 after purchasing an additional 473 shares during the period. Invesco LLC raised its position in shares of UnitedHealth Group by 7.3% in the fourth quarter. Invesco LLC now owns 1,997 shares of the healthcare conglomerate's stock valued at $1,010,000 after purchasing an additional 136 shares during the period. Finally, Allen Capital Group LLC boosted its holdings in shares of UnitedHealth Group by 5.0% during the 4th quarter. Allen Capital Group LLC now owns 10,852 shares of the healthcare conglomerate's stock worth $5,490,000 after buying an additional 515 shares during the period. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Trading Up 1.3 %
NYSE UNH traded up $7.19 on Thursday, reaching $545.29. The company had a trading volume of 2,901,680 shares, compared to its average volume of 4,583,238. The business has a 50 day moving average of $538.18 and a two-hundred day moving average of $565.09. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The firm has a market cap of $501.82 billion, a price-to-earnings ratio of 35.18, a P/E/G ratio of 1.41 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the business earned $5.83 EPS. The company's revenue was up 6.8% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.54%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group's dividend payout ratio is presently 54.19%.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on UNH. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 16th. Bank of America dropped their target price on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. Finally, HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average target price of $629.32.
Read Our Latest Report on UnitedHealth Group
Insider Activity
In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business's stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.33% of the company's stock.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.